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Introduction {#sec1}
============

Room temperature liquid metals (LMs), which particularly comprise gallium, gallium-indium eutectic alloys (EGaIn: 75% Ga, 25% In \[wt wt^−1^\]), and gallium-indium-tin alloys (Galinstan: 68.5% Ga, 21.5% In, and 10% Sn \[wt wt^−1^\]), have received increasing attention as building blocks for the design of functional composite materials because of their remarkable properties, which include superior conductivity, favorable flexibility, and high biocompatibility compared with mercury ([@bib20], [@bib16], [@bib17]). Remote manipulations of LM morphologies ([@bib55], [@bib44], [@bib23], [@bib25]) are essential techniques for these innovative material applications. However, literature studies describing LM manipulation strategies and their effect on the dynamics of these materials are scarce. Kalantarzadeh et al. reported a pH-imbalance-induced LM pump as a lab-on-a-chip mixer ([@bib64]). Tang et al. investigated the effect of voltage on LM dynamic manipulation ([@bib51]). Basically, the conventional manipulation methods of LM morphologies require contact methods such as the immersion of LMs into harsh acidic or alkaline pH solution and the attachment of an electrode onto the LM surface. The wireless and noninvasive manipulation of functional LMs operating in physiological environments has attracted considerable research interest ([@bib14], [@bib63]). For instance, Tang et al. and Zhang et al. studied wireless controlled manipulations of LM marbles by electrochemical applications ([@bib49], [@bib50], [@bib65]). Meanwhile, Tan et al. also reported photochemically induced non-contact motion of LM blobs ([@bib49], [@bib50]). Kim et al. investigated magnetic-field-induced LM droplet on-demand manipulation ([@bib32]). However, these manipulation methods are essential for physical coating of functional nanoparticles on the surface of LMs for providing driving forces for their movements. In other words, these manipulation behaviors are basically powered by performances of nanoparticles rather than by the original LM properties.

Therapeutic bioengineering is the application of engineering principles and design concepts to medicine and biology for health care purposes. The emerging field of therapeutic bioengineering has the objective of associating different classes of materials to impart functionalities toward the development of advanced devices and enhanced multifunctional modalities in different application fields, including biomedicine and theranostics ([@bib61], [@bib4], [@bib24]). Over the past several decades, the continuous growth of therapeutic bioengineering has brought innovations in the biomedical domain, thus resulting in advancements in the therapeutic, imaging, and diagnostic fields. In particular, the controlled delivery of bioactive agents and the local treatments of diseases are perspectives in the development of efficient multifunctional therapeutics ([@bib54], [@bib18]). Recent advances in therapeutic bioengineering have enabled systems and devices that respond to external stimuli such as acoustic, electromagnetic induction, or optical signals ([@bib56], [@bib59], [@bib18]). However, these physical fields are largely absorbed and scattered by tissue and similarly require a conduit for their medical treatments. By contrast, low-frequency alternating magnetic fields (AMFs) (100 kHz--1 MHz) can deeply penetrate into the body without substantial attenuation ([@bib62], [@bib15]). LMs can be integrated all-in-one and provide an innovative tool for the bioengineering of therapeutic properties under physical control ([@bib55], [@bib44], [@bib36], [@bib23], [@bib25]). Although electrical and oxidation-reduction controls of LMs have been extensively investigated, magnetic manipulations of promising LMs have not been sufficiently explored. Given these aims, the next logical step is to test these dynamic controls of LMs under AMFs suitable for various therapeutic bioengineering applications.

In this work, we examine the AMF-driven LM physiochemical properties to show that an EGaIn LM without any coating of nanoparticles exhibits unique properties under wireless AMF induction, enabling, for example, controlled directional locomotion or electromagnetic levitation. In addition, AMFs can be used to effectively eliminate tumors *in vitro* and *in vivo* via EGaIn, which dissipates heat via eddy currents. Finally, we demonstrate AMF control of the wireless dynamics of a pill-shaped microdevice composed of an LM and agarose hydrogel and trigger drug release from the device.

Results {#sec2}
=======

AMF-Modulated Three-Dimensional LM Manipulations {#sec2.1}
------------------------------------------------

Accidently, we discovered the possibility of manipulating the LM using an AMF. A glass vial containing 100 μL of the LM was positioned above the center of a magnetic coil. Under an AMF (250 A m^−1^, 245 kHz), the LM droplet instantly exhibited a "stand-up" shape with a 9-fold increase in height. Moreover, this deformation behavior was reversible via ON-OFF modulation of the AMF power ([Figure 1](#fig1){ref-type="fig"}A). Stepwise motions of an LM blob in the horizontal direction were also achieved on a glass slide by this ON-OFF switching of the AMF induction ([Figure 1](#fig1){ref-type="fig"}B and [Video S1](#mmc2){ref-type="supplementary-material"}). Conventional supermagnetostrictive materials (e.g., Galfenol \[Fe~100−*x*~Ga~*x*~\] and Terfenol-D \[Tb~0.3~Dy~0.7~Fe~1.92~\]) are known to exhibit axial displacement during magnetostriction (Galfenol, ca. 200--300 ppm \[[@bib12]\]; Terfenol-D, ca. 1500--2000 ppm \[[@bib13]\]). Visible vertical displacement of a Terfenol-D pillar was not observed after AMF induction because of its slight magnetostriction ([Figure 1](#fig1){ref-type="fig"}C).Figure 1AMF-Induced Manipulation of LM Blobs(A) AMF-modulated reversible deformation behavior of the LM. LM volume: 100 μL; AMF strength: 250 A m^−1^, 245 kHz.(B) Horizontal stepwise motions of an LM blob by ON-OFF switching mode of AMF induction. LM volume: 100 μL; AMF strength: 270 A m^−1^, 245 kHz.(C) Morphological changes of LM and Terfenol-D after AMF induction. LM volume: 100 μL; Terfenol-D volume: 707 μL; AMF strength: 250 A m^−1^, 245 kHz.

Because the LM adhered to the vial bottom, wherein its movement was disturbed by its oxide skin, we added 30 μL of water around it to introduce a slip layer between the LM and the bottom surface and then repeated the same experiment ([@bib31]). In this case, by momentary ON-OFF switching of the AMF (250 A m^−1^, 245 kHz), the water-surrounded LM (40 μL) jumped ([Figure 2](#fig2){ref-type="fig"}A) and bounced to the edge of the glass dish ([Video S2](#mmc3){ref-type="supplementary-material"}). The LM surface temperature increased to only 31.9°C from room temperature ([Figure S1](#mmc1){ref-type="supplementary-material"}) during this process, suggesting that most of the energy from the AMF was converted into kinetic energy. When the position of the LM droplets was shifted approximately 1 cm from the coil center, the same power of AMF pulse stimulation (250 A m^−1^, 245 kHz) drove all the droplets to the edge against the direction of the coil center but without the droplets exhibiting a jumping motion ([Figure 2](#fig2){ref-type="fig"}B). The movement distances of an LM could be easily controlled just by adjusting the external AMF power ([Figure S2](#mmc1){ref-type="supplementary-material"}). In general, it is difficult to manipulate solid-state materials in narrow and small spaces because of their inflexible behavior. The rigid nature of solid-state materials might restrict their ability to introduce changes in the applications to respond to the function as a building block for creating a flexible soft material. Thus to examine the potential flexibility of LM blobs in tight space, a narrow glass test tube (ca. 5 mm in diameter) was utilized to investigate the deformability of LM via AMF induction. An LM blob (30 μL, ca. 5 mm in diameter) was filled into a glass test tube with and without water. Movements of LM blobs could be successfully controlled in glass test tubes regardless of the presence or absence of water ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). We also confirmed the flexibility of an AMF-driven LM droplet using a Pasteur pipette with a relatively narrow tip (ca. 2.5 mm in diameter). An LM droplet (30 μL, ca. 5 mm in diameter) was vertically filled into the pipette. Because the diameter of the droplet was larger than that of the pipette tip, it is reasonable to think that the LM got stuck at the outlet of the tip. However, when AMF is induced, the droplet speedily comes out of the tip and eventually drops down ([Figure S3](#mmc1){ref-type="supplementary-material"}C and [Video S3](#mmc4){ref-type="supplementary-material"}). These results indicate that the AMF can induce robust movement of the LM in three-dimensional space and that such motion is related to the direction of the magnetic field relative to the position of the LM. We speculate that these dynamic transformations and controllable manipulation behaviors from simple AMF-induced LMs represent an innovation as an alternative to conventional ferrofluids, giant magnetostrictive materials ([@bib13], [@bib12]), and extreme-environment elastic materials ([@bib48]).Figure 2AMF-Modulated Three-Dimensional Locomotion of LM Blobs(A and B) Sequential snapshots of horizontal (A) and vertical (B) locomotion of the LM (40 μL) manipulated by AMF in air. AMF strength: 250 A m^−1^, 245 kHz.(C) Schematic showing the forces affecting the motion of LMs placed in different positions under the AMF.(D) Quarter-view depiction of the LM levitating over the center of the AMF coil in water.(E) Time-lapsed electromagnetic levitation images of an LM droplet (40 μL) in water. AMF strength: 250 A m^−1^, 245 kHz.

AMFs are well known to induce eddy currents in closed loops within a conductor. Because of Lenz\'s law, the created currents induce another magnetic field that opposes the external AMF, appearing as a repulsion force (Lorentz force) on the conductor ([@bib53]). The magnitude of the force is proportional to the strength of the magnetic field. Because the magnetic field is most intense at the coil center, eddy currents in the LM render a repulsive force of sufficient magnitude for the LM to overcome gravity ([Figure 2](#fig2){ref-type="fig"}C). Consequently, the LM exhibits a "jumping" action under AMF exposure. However, when the LM is outside the coil center, where the AMF direction is inclined and its strength is reduced, the LM cannot be elevated because the vertical component of the repulsive force is counteracted by its gravity. Hence, the LM, affected only by the planar component of the repulsive force, moves sideways.

Inspired by the aforementioned surprising behaviors, we sought to manipulate the LM locomotion in a steady and consistent manner. We loaded a droplet of LM (40 μL, ca. 0.4 cm in diameter) into a spindly glass test tube (ca. 0.6 cm in diameter and prefilled with deionized water) such that the tube could freely pass through the coil center, as shown in [Figure 2](#fig2){ref-type="fig"}D. Upon continuous exposure to the AMF (250 A m^−1^, 245 kHz), the LM droplet floated in the water and maintained its position over the coil center despite the glass tube being reciprocating vertically ([Figure 2](#fig2){ref-type="fig"}E and [Video S4](#mmc5){ref-type="supplementary-material"}). In addition to being attributable to the repulsive force generated by eddy currents, such a stable electromagnetic levitation behavior is attributable to the Brownian motion of water molecules surrounding the LM, which can prevent horizontal deviation of its position, thus maintaining the orientation of the repulsive force overcoming the gravity of the LM.

AMF-Mediated Exothermic Properties of LMs {#sec2.2}
-----------------------------------------

Hyperthermia therapy is a type of cancerous tumor treatment in which the body tissue is exposed to high temperatures ([@bib40]). Numerous challenges must be overcome before hyperthermia can be considered a standard treatment for cancer. Many clinical trials evaluating the effectiveness of hyperthermia are underway. Research into hyperthermia, in combination with other therapies, for the treatment of different cancers as well as improvements in existing hyperthermia techniques are urgently required. Thus we first investigated the AMF-induced potency of LMs as an effective hyperthermia technology and explored the magnetic properties of the LMs.

The AMFs used for heat dissipation experiments were generated from a flat spiral coil connected to an AC-current-tunable system (frequency fixed at 245 kHz) to vary the AMF strength. A glass vial containing 25 μL of LM and 5 mL of water was positioned above the center of the coil. As illustrated in [Figure 3](#fig3){ref-type="fig"}A, the LM increased the temperature of the solution linearly when an AMF was applied for 3 min in the *H*-field range from 110 to 270 A m^−1^. The difference in temperature (Δ*T*) reached approximately 45°C at the maximum AMF strength (*H* = 270 A m^−1^), whereas the same volume of phosphate-buffered saline (PBS) used as a control showed only a negligible increase (ca. 8°C). In another experiment, the AMF strength was fixed at *H* = 150 A m^−1^ for observation of the time-dependent heat generation properties of the LM. The change in ambient temperature of the LM increased with increasing AMF exposure and reached 32°C after 5 min ([Figure 3](#fig3){ref-type="fig"}B). To directly evaluate the LM surface temperature under the AMF, we deposited LM onto a glass slide and placed it on the coil in air. After only 3 s of exposure to the AMF (*H* = 250 A m^−1^), the temperatures of 20 μL and 40 μL of LM surprisingly increased to 121°C and 198°C, respectively ([Figure 3](#fig3){ref-type="fig"}C).Figure 3AMF-Mediated Exothermicity of an LM Blob(A) AMF-strength-dependent heating curves of the LM (25 μL, round) and PBS (25 μL, diamond) in water (5 mL). AMF duration: 3 min. Data are represented as mean ± SEM.(B) Time-dependent heating curves of the LM (25 μL, round) and PBS (25 μL, diamond) in water (5 mL). AMF strength: 150 A m^−1^, 245 kHz. Data are represented as mean ± SEM.(C) Thermal images of the LM in air before and after application of the AMF (250 A m^−1^, 245 kHz) for 3 s.

Effect of the oxide skin of the LM droplet on the increase in temperature was also investigated ([Figure S4](#mmc1){ref-type="supplementary-material"}A). The difference of temperature elevation of two LM blobs was compared in the presence or absence of 0.1 N HCl, which can prevent oxide generation on the LM surface ([@bib36], [@bib60]). After the result, the oxide skin layer of LM has no effect on the AMF-induced LM exothermicity probably because of its ultrathinness (∼1 nm) ([@bib11], [@bib34]).

The AMF-thermal conversion efficiency of the LM blob in Milli-Q (MQ) water was about 86.3%, although the efficiency was gradually decreased over time probably due to the power losses of the instrument by the strong AMF induction ([Figure S4](#mmc1){ref-type="supplementary-material"}B and see [Transparent Methods](#mmc1){ref-type="supplementary-material"} for more details). Anyway, these results demonstrate that the LM possesses excellent electromagnetic induction heating characteristics and that the amount of heat generated is readily controllable by adjusting the AMF strength, the exposure duration, and the LM volume.

*In Vitro* Cancer Elimination by AMF-Induced LM {#sec2.3}
-----------------------------------------------

Encouraged by the promising electromagnetic heating efficiency, we next evaluated the cytotoxicity and *in vitro* magnetic hyperthermia efficacy of LM using various cancer cell lines. A549 (lung carcinoma), U2OS (osteosarcoma), and HT-29 (colorectal adenocarcinoma) were first seeded in 12-well plates at 70% confluence with 1 mL medium. An LM blob (40 μL) was added to the wells and subsequently exposed to an AMF (*H* = 200 A m^−1^) for 3 min. The treated cells together with the LM were then cultured for 24 hr, and the cell viability was tested by crystal violet staining. As illustrated in [Figure 4](#fig4){ref-type="fig"}A, in the absence of the AMF, neither the LM-treated group nor the PBS control group showed any decrease in cell viability, indicating that the LM alone is less toxic. By contrast, almost all the cells incubated with the LM and then exposed to the AMF were killed. To obtain quantitative results, we conducted the same experiments using a Cell Counting Kit-8 (CCK-8 kit) and measured the temperature change. Likewise, LM without the AMF did not affect the viability. However, the viability of HT-29 cells incubated with LM decreased to 14% compared with the viability of cells in the PBS control and the temperature (20 μL of LM in 500 μL of medium) increased by 37°C simultaneously under the applied AMF (*H* = 200 A m^−1^) ([Figure 4](#fig4){ref-type="fig"}B).Figure 4*In Vitro* Cancer Elimination by AMF-Induced LM Blob(A) Crystal violet staining of cells incubated with LM or PBS following AMF treatment. The LM (40 μL) was incubated with cells in medium (1 mL) and heated under an AMF (200 A m^−1^, 245 kHz) for 3 min. Staining was performed 24 hr post treatment.(B) AMF-induced elimination of cancer cells (HT-29) by heat generation. LM (20 μL) and PBS were incubated with HT-29 in medium (500 μL) and exposed to an AMF (200 A m^−1^, 245 kHz) for 3 min. The corresponding temperature change is represented by the orange curve. Data are represented as mean ± SEM.(C) Time-dependent change in viability of cancer cell lines treated with LM (20 μL) in medium (200 μL) under an AMF (200 A m^−1^, 245 kHz). Data are represented as mean ± SEM.(D) AMF strength-dependent change in viability of cancer cell lines treated with LM (20 μL) in medium (200 μL) over a period of 10 s. Data are represented as mean ± SEM.

We next examined the cancer cell elimination effect of LM immediately after AMF treatment without an additional culture period. The magnetic hyperthermia efficacy of the LM was dependent on the AMF treatment time and strength ([Figures 4](#fig4){ref-type="fig"}C and 4D). Notably, most of the cancer cells were killed within only 10--20 s under the AMF with field strength in the range 200 ≤ *H* ≤ 240 A m^−1^. This more effective performance is attributed to the small volume of the medium (20 μL of LM in 200 μL of medium) used in this case during AMF heating. Together with the results of the viability tests, these evidences imply that LM is efficient and useful for cancer cell magnetic hyperthermia.

*In Vivo* Magnetic Thermotherapy with LMs {#sec2.4}
-----------------------------------------

The next step consisted of assessing the heating effect of the LM *in vivo* on nude mice bearing solid tumors. The biggest advantage of LM for biological applications when compared with other functional materials, such as magnetic nanoparticles, is that LMs can be easily handled as injectable liquids without chemical modifications or complicated multistep processes. Herein, we took advantage of this useful attribute of the soft and flexible liquid state of the LMs and our finding of AMF-driven LM exothermicity for *in vivo* tests. When the tumor volumes reached approximately 250 mm^3^, mice were randomly divided into four groups (*n* = 5): PBS injection only (AMF−/PBS), PBS injection and AMF exposure (AMF+/PBS), LM injection only (AMF−/LM), and LM injection and AMF exposure (AMF+/LM). Mice were intratumorally injected with 30 μL of LM or PBS and subsequently subjected or not subjected to an AMF (150 A m^−1^, 245 kHz) for 5 min. The temperatures of the tumors and mice were monitored with an infrared camera at different time intervals ([Figure 5](#fig5){ref-type="fig"}A). The tumor injected with LM underwent local heating under the applied AMF, where the temperature increased to 43.8°C (9°C increase) after 3 min and to 61.2°C (27°C increase) after 5 min. The tumor volumes and body weights of each group of mice were recorded for 16 days after treatment ([Figures 5](#fig5){ref-type="fig"}B and 5C). The tumors from all the control groups (AMF−/PBS, AMF+/PBS, and AMF−/LM) increased in size, whereas the LM-injected tumors were completely eliminated by AMF heating ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}A). Notably, the treated mice from the AMF+/LM group did not exhibit tumor recurrence or loss of body weight at the end of the experiment ([Figures 5](#fig5){ref-type="fig"}B--5D). Interestingly, a slight tumor regression was observed in the group of mice injected with LM but not subjected to AMF exposure ([Figures 4](#fig4){ref-type="fig"}B and 4C). Indeed, we observed that the tumor blood vessels were occupied by the LM after injection, as shown in [Figure S5](#mmc1){ref-type="supplementary-material"}B, suggesting that such inhibition might arise from the LM obstructing the tumor capillaries and preventing nutrient absorption ([@bib4], [@bib14]).Figure 5*In Vivo* Cancer Treatment by an AMF-Driven LM Blob(A) Thermal images of HT-29 tumor-bearing mice after intratumoral injection of the LM (30 μL) under a continuous period of AMF treatment (150 A m^−1^, 245 kHz).(B) Body weight of mice in different groups. Data are represented as mean ± SEM.(C) Growth curve of tumors in mice from different groups. The LM injection and AMF treatment were performed at 8 days (black arrow) post-transplantation of HT-29 cancer cells. Data are represented as mean ± SEM.(D) Representative photograph of the tumor tissue collected from mice in different groups 16 days post AMF treatment.

We also observed how LMs behave during AMF induction under a skin using an *ex vivo* model that is made of a pig skin and two glass slides ([Figure S6](#mmc1){ref-type="supplementary-material"} and [Video S5](#mmc6){ref-type="supplementary-material"}). Interestingly, the LM could be dramatically transformed by AMF-induced manipulation in small spaces under the skin, although most of the LM still remained in the *ex vivo* model. The LM transformations might be potentially used for their comprehensive heating and effective elimination of cancer cells. In addition, the LM could be directly removed from the injected part using this AMF-applied diverse LM motion after cancer hyperthermia, and could simultaneously effectively eliminate cancer at the target site during its movement. Anyway, we are sure that the exothermic behavior of the AMF-driven LM substantially allows effective *in vivo* cancer elimination as a flexible heat generator in physiological environments and biological systems.

AMF-Controlled Spatiotemporal Drug Release from LM Microdevice {#sec2.5}
--------------------------------------------------------------

Our final goal of the current study is to achieve remote control of an LM medical device in physiological environments for various therapeutic bioengineering purposes, particularly for cancer therapy, using the electromagnetic properties of LMs. Because of the thermal and motion capabilities rendered by an AMF, we applied the promising toxicity profile of an LM to a drug delivery system that enables controlled release of the carried therapeutic molecules at a desired location. As illustrated in [Figure 6](#fig6){ref-type="fig"}A, the LM (20 μL)-containing hydrogel depot was fabricated using 1 mL low-melting-point (≤45°C) agarose (2%, w w^−1^) and rhodamine B (RhB, 0.5 mg mL^−1^). [Figure 6](#fig6){ref-type="fig"}A shows our concept for the AMF-induced gel-sol transition of LM-agarose gel composites. Agarose gel is one of the most popular thermo-reversible hydrogels. In hot solutions, agarose chains exist in a stiff and disordered conformation. Upon cooling below 40°C, the chains settle into helices that subsequently aggregate into bundles ([@bib5]); however, the mechanism of such structural changes during the phase transition is not well understood. Here, an LM droplet was mixed at 50°C with the agarose aqueous solution and RhB was subsequently loaded as a drug model, followed by rapid cooling to form the hydrogel matrix. MQ water (2 mL) was added onto the solidified matrix and subsequently exposed to an AMF to study the thermal effect of the embedded LM on the release of RhB. After AMF exposure (200 A m^−1^, 245 kHz) for 3 min, the LM had almost thawed the whole hydrogel, leading to the complete release of RhB into the additional 2 mL water ([Figure 6](#fig6){ref-type="fig"}B).Figure 6AMF-Controlled Spatiotemporal Drug Release from an LM-Hydrogel Microdevice(A) Schematic illustration of gel-sol transition of LM-agarose gel composite upon AMF induction.(B) 1 mL hydrogel matrix (agarose, 2% w w^−1^; RhB, 0.5 mg mL^−1^) containing LM (20 μL) in addition with 2 mL water before and after AMF (200 A m^−1^, 245 kHz) exposure for 3 min.(C and D) AMF-modulated release profile (C) and temperature change (D) of LM- or PBS-containing hydrogel matrix over the period of time. The "ON" stage indicates exposure to the AMF (200 A m^−1^, 245 kHz), whereas the "OFF" stage indicates absence of the AMF.(E) Depiction of the LM/RhB-Gel microdevice consisting of LM (20 μL), agarose (2%, w w^−1^, 200 μL), RhB (0.5 mg mL^−1^), and a PCR tube.(F) Sequential snapshots of LM/RhB-Gel microdevice electromagnetic levitation induced by low-powered AMF (100 A m^−1^, 245 kHz).(G) Photograph of the LM/RhB-Gel microdevice electromagnetic levitation and RhB release behavior induced by high-powered AMF (200 A m^−1^, 245 kHz).

The same system was also used to investigate the controllability of drug release by ON-OFF cycling (30 s ON, 30 s OFF) of the AMF. As depicted in [Figures 6](#fig6){ref-type="fig"}C and 6D, in the absence of the LM, the difference in the release rate and temperature between the ON and OFF states was negligible. By contrast, under the influence of the AMF (state "ON"), the LM/hydrogel matrix exhibited a dramatic increase in temperature, with a concomitant increase in the release rate of RhB. However, when the AMF was turned OFF, the temperature change returned to ca. 0.7°C, thus barely affecting RhB release. This behavior was reproducible over five continuous ON-OFF cycles of AMF exposure (150 s ON, 150 s OFF), eventually achieving a 100% release rate. Notably, over time, the LM-induced temperature difference (Δ*T*) achieved during each ON-OFF cycle tended to decrease, which is also reflected in the reduction of the slope of the release rate curve associated with the AMF ON state. This trend is attributed to the transformation of the agarose gel to water, which has a greater specific heat capacity than the agarose gel.

To achieve the spatiotemporal targeted drug release using the LM/hydrogel system, we developed a more facile LM/RhB-Gel pill-shaped microdevice, where LM (20 μL), agarose (2%, w w^−1^, 200 μL), and RhB (0.5 mg mL^−1^) were entirely packaged in a small polymerase chain reaction (PCR) microtube (ca. 2000 μm in length and 500 μm in width) ([Figure 6](#fig6){ref-type="fig"}E). Because of the electromagnetic levitation effect of the LM, the LM/RhB-Gel microdevice was dynamically suspended in water under an AMF ([Figure 6](#fig6){ref-type="fig"}F and [Video S6](#mmc7){ref-type="supplementary-material"}). The position of the microdevice relative to its loading container could be adjusted by shifting either the AMF coil or the container. Notably, the low-powered AMF (100 A m^−1^, 245 kHz) impelling the microdevice did not trigger any diffusion of RhB (as indicated by a lack of red color in the water) during the movement. When the suspension behavior was maintained as the AMF H-field was increased to 200 A m^−1^, the LM gradually melted the surrounding agarose gel and expanded the air inside, eventually leading to a massive local release of RhB ([Figure 6](#fig6){ref-type="fig"}G). We have also confirmed RhB-releasing behavior from the improved microdevice once per day over 3 days with and without AMF application ([Figure S7](#mmc1){ref-type="supplementary-material"}).

To further confirm the thermal effect on drug release from the LM/RhB-Gel microdevice, we immersed the microdevice in 5 mL water and examined both the RhB content in the water and the temperature change under weak (100 A m^−1^, 245 kHz, for movement) or strong (200 A m^−1^, 245 kHz, for release) AMFs. As shown in [Figures S8](#mmc1){ref-type="supplementary-material"}A--S8C, within 3 min, the weak AMF only induced a slight elevation of temperature and a slight release of RhB into the water, indicating little loss of RhB during microdevice movement. By contrast, a substantial increase in RhB concentration was observed in the case of high-powered AMF exposure ([Figure S8](#mmc1){ref-type="supplementary-material"}B). Collectively, these results demonstrated that, with manipulation of the AMF strength, the designed LM/RhB-Gel microdevice could effectively release RhB to a targeted site in a water environment in which the temperature is barely affected during the microdevice transportation step.

With respect to future clinical utilization, assessments of the biosafety of the versatile LM/Gel microdevice and its thermal effect during transportation are critical. Given that agarose gel is recognized as a safe material, we examined the long-term reaction of nude mice administered LM (2 mg) by either oral feeding or intraperitoneal injection. As we expected, none of the mice administered LM showed a loss of body weight within 24 days ([Figure S8](#mmc1){ref-type="supplementary-material"}D). The *in vitro* cell viability was assessed using normal human fibroblast cells (TIG-3). Cells grown in 3 mL culture medium were exposed to a low-powered AMF (100 A m^−1^, 245 kHz) in addition to the LM/Gel microdevice. As shown in [Figure S8](#mmc1){ref-type="supplementary-material"}E, after 2 min of exposure, the microdevice did not affect cell viability immediately or 48 hr post treatment. We also confirmed that LM is less toxic in mice after subcutaneous injection, as demonstrated by various biocompatibility analyses, including blood investigations and X-ray computed tomographic (CT) scanning ([Figure S9](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}). The volume of injected LMs for subcutaneous administrations was 30 μL. Careful observations revealed no mice death with subcutaneous LM injections ([Figure S9](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}). In addition, complete blood cell count (CBC) and biochemical examinations of LM were all normal, at least for 28 days with both routes of administration ([Table S1](#mmc1){ref-type="supplementary-material"}). In particular, virtually no changes in the levels of inflammatory markers (i.e., white blood cell \[WBC\] and C-reactive protein \[CRP\]) were seen after subcutaneous injections of LM. Furthermore, we studied the distribution of LM after its subcutaneous injection into the back position by X-ray CT ([Figure S9](#mmc1){ref-type="supplementary-material"} and [Video S7](#mmc8){ref-type="supplementary-material"}). It is known that the strong X-ray attenuation property and the high density of LM are effective for *ex vivo* and *in vivo* X-ray imaging ([@bib58], [@bib14]). As a result, the injected LM could remain safely in the back of mice without toxic side effects for at least 7 days. Meanwhile, our final goal of this research is to build a functional drug delivery microdevice of LM via oral administration. Herein, the X-ray CT imaging of mice and their feces has been complementarily performed for 24 hr after oral feeding of LM to clarify the ways of excretion of LM for this future big vision. LM was apparently excreted as feces over time from the body of the mice ([Figure S10](#mmc1){ref-type="supplementary-material"}A). In fact, LM was not accumulated at all in the liver, although a very small amount of LM (small bright spots) was observed in the pyloric region of stomach, small intestine, and cecum after its oral administration for 6 hr ([Figure S10](#mmc1){ref-type="supplementary-material"}B). The X-ray bright spots derived from LMs completely disappeared after oral feeding for 24 hr ([Figure S10](#mmc1){ref-type="supplementary-material"}B). These *in vitro* and *in vivo* results indicate that the LM/Gel microdevice can potentially remotely deliver therapeutics without any side effects in a physiological environment.

We believe that various electromagnetic performances of an LM/Gel microdevice are potentially effective for remote controlling of the microdevices particularly in parts of the digestive system, such as the gullet, stomach, small intestine, and colon, as an advanced drug delivery system, in addition to the above-mentioned use of LMs in cancer elimination ([Figure S11](#mmc1){ref-type="supplementary-material"}). High controllability of the mobility of an AMF-induced LM/Gel microdevice was successfully achieved in a plastic test tube (ca. 20 mm in diameter), which is a simple model of the digestive organs ([Figure S11](#mmc1){ref-type="supplementary-material"}A). Indeed, an LM/Gel microdevice could smoothly move in a space containing PBS buffer without any stacking ([Figure S11](#mmc1){ref-type="supplementary-material"}B). These results showed that the AMF induction was sufficient to drive the magnetic characteristic of the LM/Gel microdevice under physiological conditions, thereby allowing it to easily move through a space.

Discussion {#sec3}
==========

In this study, we described the design and application of AMF-induced LM manipulations. Locomotion, electromagnetic levitation, and transformations of LM blobs, which are critical capabilities for the development of intelligent materials, could also be spatiotemporally controlled using wireless AMF applications. These high mobilities of AMF-driven LM manipulations would not only expand the concept of LMs but also provide a sophisticated movement mechanism that enables smooth, high-speed, and fine operations. At a minimum, the current three-dimensional motions of LM blobs driven by applied AMFs surpass the capabilities of ordinary LM manipulation methods ([@bib55], [@bib44], [@bib23], [@bib25]) involving electrical and oxidation-reduction reactions, which are limited to horizontal two-axis directional movements. Although electromagnetic levitation of conductive solid metals has been already reported, we believe that the unique and natural advantages of EGaIn in substantial terms of softness, flexibility, and workability in addition to the electromagnetic dynamicity allow contributing toward the creation of diverse potential applications. We are also sure that wettability of oxide layer in a self-limiting reaction is important for AMF-driven LM mobility on substrates and affinity of LMs for various biological interfaces. Indeed, the presence of the oxide layer increases the adhesion of the LMs onto oxygen-containing inorganic and organic substrates via weak but surface-dispersed van der Waals forces ([@bib10]).

Upon AMF induction, the LM droplets were rapidly heated via an eddy current. The heating capacity of an electrically conductive material is related to eddy currents generated by electromagnetic induction; these eddy currents lead to Joule heating ([@bib26]). The favorable electrical conductivity (3.46 × 10^6^ S m^−1^) of LM ([@bib30]) enables the AMF to induce an eddy current passing through the LM and thus produce substantial heat. On the basis of the skin effect, eddy current heating is strongly associated with the size and geometry of the conductor ([@bib7]). Therefore if the resistivity of the LM is assumed to be constant, then a larger volume of LM exhibiting a greater surface area is reasonably expected to provide better heat generation performance ([Figure 3](#fig3){ref-type="fig"}C). Notably, conventional nanoparticles used for magnetic hyperthermia required a high-powered AMF with a typical amplitude and frequency (*Hf*) on the order of 10^9^ Am^−1^ s^−1^ ([@bib45]). Moreover, an *Hf* factor greater than 5 × 10^9^ Am^−1^ s^−1^ is potentially harmful for patients ([@bib27]). By contrast, LM demonstrates excellent heat generation performance with an *Hf* factor on the order of 10^7^ Am^−1^ s^−1^, which is two orders of magnitude smaller than that needed for magnetic nanoparticles. Meanwhile, the maximum magnetic field strength of our system (270 A m^−1^) is about 10,000-fold lower than those used for conventional magnetic resonance imaging (MRI) (239 × 10^4^ A m^−1^) ([@bib52]). We believe that the magnetic field strength of our system may not be a crucial issue for local fields just by being careful to apply them away from sensitive areas. Thus from the viewpoint of energy consumption and safety of the AMF, LM is a promising material for magnetic hyperthermia technology. Indeed, our results also show that LMs under an applied AMF can be used to effectively eliminate *in vitro* and *in vivo* cancer cells because of their powerful exothermicity.

Near-infrared (NIR) light, radio frequency (RF), microwave (MW), ultrasound (US), and AMF are the most commonly used technological platforms for cancer hyperthermia. The maximum penetration depth of NIR light in a biological tissue is of the order of a few millimeters, making this approach quite inefficient for the treatment of deep tumors ([@bib39], [@bib47]). RF ablation also presents important limitations owing to its poor depth penetration, resulting in severe invasiveness and incomplete tumor destruction ([@bib19], [@bib3]). The penetration of MW in biological tissues is also very poor ([@bib57]). Moreover, the focal spot generated by MW is unsatisfactory at the normal-cancerous tissue interface because of the long wavelength of the MW. US can achieve much better penetration depths than MW ([@bib21]). However, because its acoustic wavelength is very short, the focal spot generated by US is very small (millimeter or submillimeter in diameter) compared to a large tumor (centimeters in diameter on the average). Thus many focal spots are required for complete tumor coverage, which results in long treatment and missed cancer cells. With AMF approach there are no limitations to the penetration depth ([@bib8], [@bib33], [@bib41]). We confirmed that AMF certainly penetrated thick pig skins (at least 3 cm) to effectively generate thermal energy from the LM droplet by the simple AMF laboratory instrument ([Figure S12](#mmc1){ref-type="supplementary-material"}). Herein, we believe that AMF-driven LM hyperthermia would overcome the problem of traditional treatments.

Two techniques are currently used to deliver the nanoparticles to the tumor for hyperthermia. The first is to deliver particles to the tumor vasculature ([@bib37]) through its supplying artery; however, this method is not effective for poorly perfused tumors. Furthermore, for a tumor with an irregular shape, inadequate nanoparticle distribution may cause under-dosage of heating in the tumor or overheating of the normal tissue. The second approach is to directly inject nanoparticles into the extracellular space in the tumors ([@bib43]). The nanoparticles diffuse inside the tissue after injection of the nanofluid. However, nanoparticles tend to easily disappear from the target site after injection owing to their small particle size. As a result, nanoparticles lose their effective heating property. It means that repeated heating of nanoparticles is not available for long duration, although surviving cancer cells are often regenerated at the same position. Eventually, nanoparticles should be injected each time there is cancer recurrence. This is disadvantageous in terms of the quality of a patient\'s life. LM could be implanted on a long-term basis for cancer hyperthermia in a similar way as solid metal-based implant materials and devices (e.g., artificial bone and pacemaker). In fact, gallium-based LMs worked as implantable teeth materials with high biocompatibility ([@bib29], [@bib22]). Anyway, owing to the fluidity of LM, a tumor with an irregular shape can be sufficiently covered by introducing LM in a proper manner. In addition, repetitive exothermic behavior from AMF-induced LM might be useful for cancer eradication to prevent cancer recurrence and metastasis in future practical situations.

Ordinary ferrofluids composed of magnetic nanoparticles have the advantages of nanosized effects, such as heat homogeneity and tumor-specific accumulation ability. However, AMF-induced exothermic behavior of a commercially available ferrofluid was less than that of the LM system ([Figure S13](#mmc1){ref-type="supplementary-material"}). In addition, ferrofluid easily dries up just after incubation for only an overnight even at ambient temperature and is then transformed to a hard-state solid material that is inconvenient to handle ([Figure S14](#mmc1){ref-type="supplementary-material"}A). LMs are highly stable and can keep in liquid state for long period at normal temperature because of their non-volatility.

Meanwhile, it is well known that gold and silver nanoparticles are unstable to heating and freezing owing to the shape deformations (degradation) ([@bib2], [@bib66]). In addition, these metal nanoparticles do not have high dispersing stability in aqueous solution, including salts such as buffers and cell culture media ([@bib9]). Furthermore, heat generation from these metal nanoparticles basically requires relatively higher frequency (mainly 13.56 MHz) AMF that has low biological permeability ([@bib1]). LMs have very high thermal stability. Indeed, LM blobs were obviously stable even after repetitive heating in salt solution by AMF application ([Figure S14](#mmc1){ref-type="supplementary-material"}B). The exothermic ability of LMs is also driven by low-frequency AMF (245 kHz) that can deeply penetrate into the body ([@bib62], [@bib15]).

The nanodimensional properties of magnetic nanoparticles can potentially lead to toxic side effects at the molecular level, such as inflammation, impaired mitochondrial function, and gene damage ([@bib28], [@bib42], [@bib6], [@bib46]), during their applications in physiological environments. From these perspectives, LMs for the possible treatment of malignant epithelial tumors have become an area of interest because they can be manipulated as a bulk material. Nevertheless, ligand (e.g., antibody and peptide)-functionalized LM nano/micro particles are also emerging as promising agents for future targeted cancer therapy ([@bib36], [@bib14]). However, LM nano/micro particles do not have strong exothermicity by AMF application compared with LM blobs regardless of the presence or absence of chemical functionalization with poly(ethylene glycol) methyl ether thiol (PEGMET) probably due to their low electromagnetic property associated with size effect ([Figure S15](#mmc1){ref-type="supplementary-material"}). We are, thus, currently improving the efficacy and selectivity of an AMF-induced LM nano/micro particle technology by investigating on the unique shape and optimal size of the particles for effective and targeted cancer elimination. Meanwhile, the dynamic behavior of these LM nano/micro particles cannot be controlled at all by AMF application because the size effect of LM is also strongly affected on manipulation ([Figure S16](#mmc1){ref-type="supplementary-material"}). We are currently exploring the optimal size of LM droplets for applying the AMF-driven technology in medical devices on chips ([@bib24]).

Although conventional ferrofluids are also controllable by AMF application for remote manipulation as well as the current AMF-induced LM system, the mobilities of an AMF-induced ferrofluid are quite insufficient compared with our LM system in physiological environment ([Figure S17](#mmc1){ref-type="supplementary-material"} and [Video S8](#mmc9){ref-type="supplementary-material"}). Twenty microliters of ferrofluid (sodium tetradecene sulfonate-modified magnetite nanoparticles-distilled water suspension, ca. 35 wt% in concentration and ca. 10 nm in diameter) was loaded into a spindle-shaped glass tube that was prefilled with 3 mL water. After concentrating ferrofluids to the bottom by centrifugation, the glass tube was horizontally placed and we approached the glass tube onto the coil center at a constant speed. Along with the tube shifting, LM was keeping its integrity and position steady as expected. However, although dense ferrofluids were attracted by AMF, a large amount of them were left behind. Indeed, ferrofluid is rapidly diffused and dispersed in aqueous solution. After all, their mobilities are not controllable at all by AMF induction. We also investigated the AMF-controlled motion of diluted ferrofluids (5 μL in 3 mL water, simple spin-down), which is much more similar to physiological condition. The diluted ferrofluids did not show any relative movement at all in the glass tube, indicating that ferrofluids may not be controllable by AMF when the magnetic particles are tenuous. Taken together, AMF-induced LM clearly represents high controllability in physiological conditions. In addition, high biocompatibility and non-volatility of LM are advantages over conventional ferrofluids, which are basically prepared by toxic surfactants and volatile solvents.

Furthermore, the pill-shaped microdevice based on LM and agarose hydrogel composites is remotely levitated and releases drug molecules in a controlled manner under an applied AMF. This study is the first to exploit the powerful electromagnetic properties of LMs for eradication of cancer cells, achieving basic motion and melting drugs containing hydrogels. The findings described herein provide a valuable therapeutic bioengineering and related biotechnology with potential applications in various scientific fields, including cancer research and electromagnetic materials science. We believe the dramatic morphological changes of LM triggered by AMF induction could also be useful in the development and design of magnetostrictive materials ([@bib13], [@bib12]) and extreme-environment actuators ([@bib48]). The strategy used in this study addresses several fundamental issues related to the fabrication of biocompatible microdevices. The entire LM consists of low-toxicity EGaIn, and its performance is driven by simple electromagnetic mechanisms. LM itself can also be easily removed from the biological system after operations, when it is packed in a pill-shaped microdevice, to prevent accidents from other magnetic fields. In addition, we expect that the manipulation capabilities of the LM system are effectively controlled in the stomach and intestines because there are huge spaces for controlling the movement of LMs. These AMFs controlled the wireless dynamics of a pill-shaped microdevice and triggered the spatiotemporal drug release, which could be also useful as oral and intrarectal drug delivery systems for future cancer elimination. The electromagnetic hyperthermia of LMs could be also utilized in combination with chemotherapy to improve cancer cell elimination in the stomach and intestines, since hyperthermia can render tumor cells temporarily more sensitive to the synergetic damaging effects of chemotherapeutics. This work is a proof-of-principle study demonstrating that *in vitro* operations of LM devices can be mediated by AMF induction. Further studies are needed to investigate *in vivo* manipulation systems and appropriate design of devices and construction of suitable animal models to determine the effective performance of an LM device in a deep digestive organ for advanced drug delivery systems.

Previous works on drug delivery microdevices have been focused mainly on the sustained release of a single compound whose release profile must be determined; in addition, these microdevices usually have complicated and invasive mechanisms for triggering delivery ([@bib61], [@bib54]). The three-dimensional spatial position of the LM pill-shaped microdevice can be accurately controlled and triggered to release drug molecules. Given these capabilities, our microdevice could find applications in advanced drug delivery and other applications that require control of microenvironments around cancerous tumors and could bring the field one step closer to the development of functional materials that can safely interact with humans and other living systems.

Although research groups have reported functional ferrogels---the use of a uniform magnetic field for directionally controlled drug releasing---we find that ordinary ferrogels are inferior in size effect ([@bib35]). In general, the magnetic responses of composites are dramatically decreased when they have large thickness. In other words, conventional ferrogels cannot be prepared in fixed shapes like a thin membrane. In addition, it is necessary to construct an optimal magnetic field distribution system for sufficient magnetic responsibility to release drug molecules. Furthermore, the materials must be carefully designed for complicated interfacial affinity between the magnetic nanoparticle and the gel matrix owing to the low dispersibility of magnetic nanoparticles in matrixes. In light of this fact, it has been demonstrated that various shapes of composites such as cylindrical and pill-shaped devices can be easily prepared, control release of RhB is achieved by simple AMF irradiation without consideration of complicated magnetic field distribution system; oxidized skin layer of LM allows improving the interfacial affinity at the interface of the LM and hydrogel matrix.

The attractive properties of LMs such as fluidity may also render them better suited to some applications of the drug delivery system than other electromagneto-responsive gels such as hybrid gel encapsulating aluminum cramps. The fluidity of LM might be useful to prepare a pill-shaped microdevice indeed because LM can be conveniently handled as a liquid using simple pipetting technique for filling into a device. The fluidity of LM can also possibly seem to be causing physical damages on a biological tissue when the LM accidently comes out from the device during heating. Meanwhile, electromagnetic solid materials like aluminum require fabrication (cutting, molding and filling, etc.) for making a microdevice. Hardness and robustness of solid aluminum also possibly lead to harmful physical sticking onto the tissues. At least, we confirmed low heat generation of aluminum clumps by AMF induction ([Figure S13](#mmc1){ref-type="supplementary-material"}). Indeed, the AMF-induced exothermic property of aluminum clumps was lower than that of the LM system under the same conditions. Furthermore, we believe that fluidity of LM is also an important factor in both cancer thermotherapy and drug delivery devices because it contributes to injectability and effective heating process. For cancer hyperthermia, fluidity of LM is able to effectively heat the entire target region that is comprehensively enclosed by injection of LM. On the other hand, patterning and multi-heating points are easily designed in the LM/agarose gel composite for AMF-induced acceleration of decomposition speed of gel matrix ([Figure S18](#mmc1){ref-type="supplementary-material"}). Taken together, we are sure that the AMF-driven LM system has fruitful advantages to build up smart microdevices, particularly in terms of fluidity that can be convenient handled and powerful exothermic property for the potential use to develop innovative therapeutic bioengineering.
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All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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